Overweight or Obesity
Metabolic·MeSH: Obesity
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
4 drugs in development·3 companies·13 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| plenity | GELESIS HOLDINGS, INC. (GLS) |
Phase 3(1)
Phase 2(1)
Phase 1(1)
| Drug | Company |
|---|---|
| LY4064912 | ELI LILLY & Co (LLY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Overweight or Obesity?
BioSniper tracks 4 drugs in development for Overweight or Obesity across 3 companies.
How many clinical trials target Overweight or Obesity?
There are 13 clinical trials targeting Overweight or Obesity tracked by BioSniper.
What is the prevalence of Overweight or Obesity?
The estimated prevalence of Overweight or Obesity is approximately 42000.0 per 100,000 population.
Deep-dive into Overweight or Obesity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis